|
Volumn 10, Issue 2, 2000, Pages 135-137
|
Antiviral developments
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBIOTIC AGENT;
ANTIVIRUS AGENT;
OSELTAMIVIR;
SIALIDASE;
SIALIDASE INHIBITOR;
UNCLASSIFIED DRUG;
ZANAMIVIR;
CLINICAL TRIAL;
DRUG BIOAVAILABILITY;
DRUG POTENCY;
DRUG SELECTIVITY;
DRY POWDER;
HUMAN;
INFLUENZA;
INFLUENZA VACCINATION;
INFLUENZA VIRUS A;
INFLUENZA VIRUS B;
NAUSEA;
NONHUMAN;
SHORT SURVEY;
VOMITING;
ANTIVIRAL AGENTS;
CLINICAL TRIALS;
DRUG DESIGN;
ENZYME INHIBITORS;
HUMAN;
NEURAMINIDASE;
|
EID: 0034098824
PISSN: 10529276
EISSN: None
Source Type: Journal
DOI: 10.1002/(SICI)1099-1654(200003/04)10:2<135::AID-RMV276>3.0.CO;2-M Document Type: Short Survey |
Times cited : (4)
|
References (5)
|